The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort

Philippa d.k. Curry; Hector Chinoy; Meghna Jani; Darren Plant; Kimmie l. Hyrich; Ann w. Morgan; A.g. Wilson; John d. Isaacs; Andrew p. Morris; Anne Barton; James Bluett

doi:10.3899/jrheum.2022-1277

The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort

Philippa d.k. Curry, Hector Chinoy, Meghna Jani, Darren Plant, Kimmie l. Hyrich, Ann w. Morgan, A.g. Wilson, John d. Isaacs, Andrew p. Morris, Anne Barton, James Bluett

Research output: Contribution to journal › Letter › peer-review

Abstract

Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response.1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.

Original language	English
Pages (from-to)	jrheum.2022-1277
Journal	The Journal of rheumatology
Early online date	15 Jun 2023
DOIs	https://doi.org/10.3899/jrheum.2022-1277
Publication status	E-pub ahead of print - 15 Jun 2023

Access to Document

10.3899/jrheum.2022-1277

Centre for Epidemiology Versus Arthritis.
Dixon, W., Bruce, I., Felson, D., Hyrich, K., Lunt, M., Mcbeth, J., Mcdonagh, J., O'Neill, T., Sergeant, J., Verstappen, S. & Serafimova, I.
1/08/18 → 14/03/24
Project: Research

Cite this

Curry, P. D. K., Chinoy, H., Jani, M., Plant, D., Hyrich, K. L., Morgan, A. W., Wilson, A. G., Isaacs, J. D., Morris, A. P., Barton, A., & Bluett, J. (2023). The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort. The Journal of rheumatology, jrheum.2022-1277. Advance online publication. https://doi.org/10.3899/jrheum.2022-1277

@article{6466d30d9bd84204a24551b6ec4afafd,

title = "The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort",

abstract = "Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response.1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.",

author = "Curry, {Philippa d.k.} and Hector Chinoy and Meghna Jani and Darren Plant and Hyrich, {Kimmie l.} and Morgan, {Ann w.} and A.g. Wilson and Isaacs, {John d.} and Morris, {Andrew p.} and Anne Barton and James Bluett",

year = "2023",

month = jun,

day = "15",

doi = "10.3899/jrheum.2022-1277",

language = "English",

pages = "jrheum.2022--1277",

journal = "The Journal of rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology Publishing Co. Ltd",

}

TY - JOUR

T1 - The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort

AU - Curry, Philippa d.k.

AU - Chinoy, Hector

AU - Jani, Meghna

AU - Plant, Darren

AU - Hyrich, Kimmie l.

AU - Morgan, Ann w.

AU - Wilson, A.g.

AU - Isaacs, John d.

AU - Morris, Andrew p.

AU - Barton, Anne

AU - Bluett, James

PY - 2023/6/15

Y1 - 2023/6/15

N2 - Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response.1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.

AB - Suboptimal treatment adherence has been reported in patients with arthritic diseases; is associated with psychological factors, including anxiety; and correlates with future treatment response.1,2 During the coronavirus disease 2019 (COVID-19) pandemic, patients who identified as clinically extremely vulnerable, including people prescribed ≥ 2 immunosuppressives, were advised to shield and continue treatment unless they developed COVID-19 symptoms.

U2 - 10.3899/jrheum.2022-1277

DO - 10.3899/jrheum.2022-1277

M3 - Letter

SN - 0315-162X

SP - jrheum.2022-1277

JO - The Journal of rheumatology

JF - The Journal of rheumatology

ER -

The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort

Abstract

Access to Document

Fingerprint

Projects

Centre for Epidemiology Versus Arthritis.

Cite this